Cargando…

Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy

Detalles Bibliográficos
Autores principales: Mohan Singh Sindhi, Rithik, Ahmad, Mahmood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982277/
https://www.ncbi.nlm.nih.gov/pubmed/36875900
http://dx.doi.org/10.1016/j.jaccao.2022.10.012
_version_ 1784900295274266624
author Mohan Singh Sindhi, Rithik
Ahmad, Mahmood
author_facet Mohan Singh Sindhi, Rithik
Ahmad, Mahmood
author_sort Mohan Singh Sindhi, Rithik
collection PubMed
description
format Online
Article
Text
id pubmed-9982277
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99822772023-03-04 Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy Mohan Singh Sindhi, Rithik Ahmad, Mahmood JACC CardioOncol Letter to the Editor Elsevier 2023-02-21 /pmc/articles/PMC9982277/ /pubmed/36875900 http://dx.doi.org/10.1016/j.jaccao.2022.10.012 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Mohan Singh Sindhi, Rithik
Ahmad, Mahmood
Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy
title Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy
title_full Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy
title_fullStr Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy
title_full_unstemmed Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy
title_short Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy
title_sort novel technologies must be considered for childhood cancer survivors at risk for cardiomyopathy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982277/
https://www.ncbi.nlm.nih.gov/pubmed/36875900
http://dx.doi.org/10.1016/j.jaccao.2022.10.012
work_keys_str_mv AT mohansinghsindhirithik noveltechnologiesmustbeconsideredforchildhoodcancersurvivorsatriskforcardiomyopathy
AT ahmadmahmood noveltechnologiesmustbeconsideredforchildhoodcancersurvivorsatriskforcardiomyopathy